Lawsuits Allege GranuFlo and Naturalyte Can Cause Sudden Cardiac Events, Death

December 18, 2013

Important Information

Attorneys working with ClassAction.org are no longer reviewing claims for this case. The information here is for reference only. A list of open investigations can be viewed here.

Comments |

At A Glance

This Alert Affects
Patients who underwent hemodialysis treatment using GranuFlo or Naturalyte.
What Are GranuFlo and Naturalyte?
Naturalyte GranuFlo powder and Naturalyte Liquid Acid concentrate are used during hemodialysis to treat acute or chronic kidney failure.
Side Effects
Heart attack, low blood pressure, arrhythmia (irregular heartbeat), cardiac arrest and death.
Manufacturer
Fresenius Medical Care.
Recall
In 2012, the FDA issued a Class I recall for Naturalyte and GranuFlo after the agency found that the dialysis treatments, when inappropriately prescribed, could put patients at risk for low blood pressure, arrhythmia (irregular heartbeat) and sudden cardiac death.
Type of Lawsuit
Mass Tort